Cytokinetics(CYTK) Stock Price Today | Quotes & News

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US Stock MarketDetailed Quotes

CYTK Cytokinetics

Watchlist

45.430
+2.330+5.41%

Close Mar 21 16:00 ET

45.750
+0.320+0.70%

Post 18:17 ET

5.38BMarket Cap-8.64P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Scholastic Posts Strong Earnings, Joins Ouster, Torrid Holdings, Adaptive Biotechnologies And Other Big Stocks Moving Higher On Friday
BenzingaMar 21 10:29 ET
Cytokinetics Announces Launch of EARTH-HCM, a Public Health Education Tool for the Hypertrophic Cardiomyopathy Community
GlobeNewswireMar 20 07:30 ET
Express News | Cytokinetics Announces Launch of Earth-HCM, a Public Health Education Tool for the Hypertrophic Cardiomyopathy Community
ReutersMar 20 07:30 ET
H.C. Wainwright Maintains Cytokinetics(CYTK.US) With Buy Rating, Maintains Target Price $120
Moomoo NewsMar 19 00:33 ET · Ratings
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswireMar 18 16:00 ET
Express News | Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
ReutersMar 18 16:00 ET

Comments

Teddy123

Mar 20 19:46

Cytokinetics Announces Launch of EARTH-HCM, a Public Health Education Tool for the Hypertrophic Cardiomyopathy Community

$Cytokinetics (CYTK.US)$
Groundbreaking Healthcare Tool Unlocks Insights from 65,000 Pharmacies' HCM Data

Narga101

Feb 21 07:35

hidden gem right here

$Cytokinetics (CYTK.US)$

Movers and Shakers

Dec 24, 2024 21:57

Columns Today's Pre-Market Movers and Top Ratings | TIVC, NEUE, X, and More

Morning Movers
Gapping up
$Tivic Health Systems (TIVC.US)$ shares jumped 76% in Tuesday premarket after CEO Jennifer Ernst announced plans for 2025 cash flow initiatives and disease-specific clinical trials for regulatory approvals.
$NeueHealth (NEUE.US)$ stock surged 62% after announcing its agreement to be acquired and taken private by a New Enterprise Associates affiliate in a deal valued at approximately $1.3 billion.
$SEALSQ Corp (LAES.US)$ shares c...

Sean Parker

Nov 19, 2024 16:56

$Cytokinetics (CYTK.US)$
Cytokinetics (CYTK) and Bayer have established an exclusive licensing agreement for aficamten in Japan, focusing on treating hypertrophic cardiomyopathy (HCM). The deal includes an upfront payment of €50 million to Cytokinetics, with potential additional earnings of €90 million in milestones through commercial launch (including €20 million near-term) and up to €490 million in commercial milestone payments. The collaboration involves tiered royalties on Japanese sales and ...

Mr Long Term

Aug 14, 2024 06:42

Columns Top Calls on Wall Street: Starbucks, Dell, Warner Bros. and More.

Top 5 Upgrades:
Baird upgraded Starbucks $Starbucks (SBUX.US)$ to Outperform from Neutral with a price target of $110, up from $81. The firm sees a more favorable risk/reward on Starbucks shares following the hiring of Brian Niccol as CEO.
Barclays upgraded Dell Technologies $Dell Technologies (DELL.US)$ to Equal Weight from Underweight with an unchanged price target of $97. The firm says much of the artificial intelligence "hype" ...